Published • loading... • Updated
Devonian Health Group Is Authorized by Health Canada to Evaluate a New Formulation of Thykamine(TM) to Prevent Radiation-Induced Skin Damage in Breast Cancer Patients
Summary by Les Affaires
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A new exclusive formulation of ThykamineTM at 0.1% expands Devonian's clinical development program to oncology support care,
·Montreal, Canada
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
